TY - JOUR
T1 - ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
AU - Cibula, David
AU - Raspollini, Maria Rosaria
AU - Planchamp, François
AU - Centeno, Carlos
AU - Chargari, Cyrus
AU - Felix, Ana
AU - Fischerová, Daniela
AU - Jahnn-Kuch, Daniela
AU - Joly, Florence
AU - Kohler, Christhardt
AU - Lax, Sigurd
AU - Lorusso, Domenica
AU - Mahantshetty, Umesh
AU - Mathevet, Patrice
AU - Naik, Raj
AU - Nout, Remi A.
AU - Oaknin, Ana
AU - Peccatori, Fedro
AU - Persson, Jan
AU - Querleu, Denis
AU - Bernabé, Sandra Rubio
AU - Schmid, Maximilian P.
AU - Stepanyan, Artem
AU - Svintsitskyi, Valentyn
AU - Tamussino, Karl
AU - Zapardiel, Ignacio
AU - Lindegaard, Jacob
N1 - Funding Information:
Open access publishing supported by the National Technical Library in Prague.
Funding Information:
The authors thank ESGO, ESTRO, and ESP for their support. The authors also thank the 155 international reviewers (physicians and patient representatives, see Appendix 2 ) for their valuable comments and suggestions. The authors thank the ESGO office, especially Kamila Macku, Tereza Cicakova, and Kateřina Šibravová, provided invaluable logistical and administrative support throughout the process.
Publisher Copyright:
© 2023, ESGO, ESTRO, ESP.
PY - 2023/6
Y1 - 2023/6
N2 - In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer. To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives. These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
AB - In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer. To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives. These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
UR - http://www.scopus.com/inward/record.url?scp=85158102541&partnerID=8YFLogxK
U2 - 10.1007/s00428-023-03552-3
DO - 10.1007/s00428-023-03552-3
M3 - Article
C2 - 37127326
AN - SCOPUS:85158102541
SN - 0945-6317
VL - 482
SP - 935
EP - 966
JO - Virchows Archiv
JF - Virchows Archiv
IS - 6
ER -
